Content
Parachute Falsification, The FDA And Non-Science
Article By:
Bronte Capital
Read
Sunday, November 17, 2013 9:11 PM EDT
I seem to have annoyed some statistics fundamentalists with the last statistics post.
In this article: GCVRZ
Weekend Market Talk
Article By:
TalkMarkets DailyTalk
Read
Sunday, November 17, 2013 3:53 PM EDT
Read about what's been happening.
In this article: LNKD
13F Files Are Out Leading To Heavy Trading
Article By:
Vivian Lewis
Read
Sunday, November 17, 2013 7:00 AM EDT
Today is information overload day for stock watchers because the 13F files of US funds have been filed and collated by the wire services. Many large cap shares were heavily traded in Q3, including many of ours.
In this article: BAVA.CO, ABV, ABX, ALU, COV, CZZ, GSK, NOK, PKX, SBS, SLB, ICL.TA, GIFD, CSIQ, TEVA, CUBA
The FDA, Statistics And Fundamentalism
Article By:
Bronte Capital
Read
Thursday, November 14, 2013 9:15 PM EDT
Say you're going to jump out of an airplane. Do you need a double-blind study to convince you to take the parachute on your way out?
Large Cap Report
Article By:
E.B. Capital Markets
Read
Tuesday, November 12, 2013 11:51 PM EDT
Lists of best stocks and worse stocks.
A Wild Ride: Ended On A High Note
Article By:
Dr. Paul Price
Read
Friday, November 8, 2013 9:08 PM EDT
Market Shadows' Value Portfolio reached a new weekly closing high.
See how we've done and what was bought and sold during the week just ended.
In this article: HFC
Afternoon Reading
Article By:
TalkMarkets DailyTalk
Read
Thursday, November 7, 2013 2:44 PM EDT
Tweet this.
In this article: TSLA
Stock Sector Report
Article By:
E.B. Capital Markets
Read
Wednesday, November 6, 2013 1:33 PM EDT
Scoring and comparing different sectors of the stock market.
Large Cap Best & Worst Report
Article By:
E.B. Capital Markets
Read
Wednesday, November 6, 2013 7:00 AM EDT
Best and worst lists of large cap stocks.
Twitter Up, Teva Down, Blackberry... Dead? And Other Top Stories & Scandals
Article By:
TalkMarkets DailyTalk
Read
Monday, November 4, 2013 6:00 PM EDT
Today had some ups and downs for some popular companies including Twitter, Teva, Blackberry, Bitcoin, Johnson & Johnson and Apple.
Say 'Neva Sell Teva' No More
Article By:
Vivian Lewis
Read
Monday, November 4, 2013 3:00 PM EDT
With Teva facing a board and top management in disarray, layoffs, a worker's strike, government criticism and more, it's time to sell.
In this article: TEVA
The Q Ratio And Market Valuation: Monthly Update
Article By:
Doug Short
Read
Monday, November 4, 2013 1:38 PM EDT
Is the market overprices? A look at the Q ratio.
In this article: SPY
Too Many Quarterlies
Article By:
Vivian Lewis
Read
Friday, November 1, 2013 4:25 PM EDT
Updates on Teva, Barrick Gold, Bombardier, AmBev, Ecopetrol, Dr Reddy, Posco's, Paddy Power plc, Odontoprev, Maxichem, Israel Chemicals and Potash of Saskatchewan.
Today's DailyTalk
Article By:
TalkMarkets DailyTalk
Read
Thursday, October 31, 2013 3:59 PM EDT
Here's what we're reading. It's all good.
In this article: DNDN, GOOG, ORCL, RHT NOW IBM
The Case For Shorting Myriad Genetics
Article By:
Ketan Desai
Read
Friday, October 4, 2013 11:00 AM EDT
Many articles have been written about Myriad Genetics (MYGN) – some bullish, some bearish. This is a bearish article, looking at the company from a different angle.
In this article: MYGN
The Company You Keep Speaks Volumes: Novabay And Trius
Article By:
John Eastman
Read
Thursday, October 3, 2013 4:18 PM EDT
The great potential of a drug or remedy that may make it a significant seller and revenue driver for years to come is one thing. But the partners and interested parties early on suggests a depth that a long term stakeholder should pay attention to.